TPV 250 (Aptivus 250 mg)
Generic Name: tipranavir
Pill with imprint TPV 250 is Pink, Capsule-shape and has been identified as Aptivus 250 mg. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc.
Aptivus is used in the treatment of hiv infection and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Aptivus 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TPV 250
Aptivus
- Generic Name
- tipranavir
- Imprint
- TPV 250
- Strength
- 250 mg
- Color
- Pink
- Size
- 22.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Boehringer Ingelheim Pharmaceuticals, Inc.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00597-0003 | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 54569-5719 | A-S Medication Solutions, LLC (repackager) |
More about Aptivus (tipranavir)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- Pricing & coupons
- En español
- Drug class: protease inhibitors
- FDA approval history
Patient resources
- Drug Information
- Aptivus (Advanced Reading)
- Aptivus (Tipranavir Capsules)
- Aptivus (Tipranavir Oral Solution)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.